MedTrace Logo

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

NCT02954068 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 543

Last updated 2018-04-30

No results posted yet for this study

Summary

This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

IV Oxytocin + IM placebo

DRUG

IM Oxytocin + IV placebo

Sponsors & Collaborators

  • Centro Rosarino de Estudios Perinatales (CREP)

    collaborator UNKNOWN

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

  • Ilana Dzuba, MPH · Gynuity Health Projects

  • Guillermo Carroli, MD · Centro Rosarino de Estudios Perinatales (CREP)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-09-30
Completion
2017-10-01

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02954068 on ClinicalTrials.gov